Home
>
National Drug Code (NDC)
>
Mavik
Mavik - 0074-2280-13 - (Trandolapril)
Drug Information of Mavik
| Product NDC: | 0074-2280 |
| Proprietary Name: | Mavik |
| Non Proprietary Name: | Trandolapril |
| Active Ingredient(s): | 4 mg/1 & nbsp; Trandolapril |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Mavik
| Product NDC: | 0074-2280 |
| Labeler Name: | Abbott Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020528 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960426 |
Package Information of Mavik
| Package NDC: | 0074-2280-13 |
| Package Description: | 100 TABLET in 1 BOTTLE (0074-2280-13) |
NDC Information of Mavik
| NDC Code | 0074-2280-13 |
| Proprietary Name | Mavik |
| Package Description | 100 TABLET in 1 BOTTLE (0074-2280-13) |
| Product NDC | 0074-2280 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Trandolapril |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19960426 |
| Marketing Category Name | NDA |
| Labeler Name | Abbott Laboratories |
| Substance Name | TRANDOLAPRIL |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
